Predictive model for the preoperative assessment and prognostic modeling of lymph node metastasis in endometrial cancer

被引:0
作者
Yuka Asami
Kengo Hiranuma
Daisuke Takayanagi
Maiko Matsuda
Yoko Shimada
Mayumi Kobayashi Kato
Ikumi Kuno
Naoya Murakami
Masaaki Komatsu
Ryuji Hamamoto
Takashi Kohno
Akihiko Sekizawa
Koji Matsumoto
Tomoyasu Kato
Hiroshi Yoshida
Kouya Shiraishi
机构
[1] National Cancer Center Research Institute,Division of Genome Biology
[2] Showa University School of Medicine,Department of Obstetrics and Gynecology
[3] Juntendo University,Department of Obstetrics and Gynecology, Faculty of Medicine
[4] National Cancer Center Hospital,Department of Gynecology
[5] National Cancer Center Hospital,Department of Radiation Oncology
[6] National Cancer Center Research Institute,Division of Medical AI Research and Development
[7] RIKEN Center for Advanced Intelligence Project,Cancer Translational Research Team
[8] National Cancer Center Hospital,Division of Diagnostic Pathology
来源
Scientific Reports | / 12卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Lymph node metastasis (LNM) is a well-established prognostic factor in endometrial cancer (EC). We aimed to construct a model that predicts LNM and prognosis using preoperative factors such as myometrial invasion (MI), enlarged lymph nodes (LNs), histological grade determined by endometrial biopsy, and serum cancer antigen 125 (CA125) level using two independent cohorts consisting of 254 EC patients. The area under the receiver operating characteristic curve (AUC) of the constructed model was 0.80 regardless of the machine learning techniques. Enlarged LNs and higher serum CA125 levels were more significant in patients with low-grade EC (LGEC) and LNM than in patients without LNM, whereas deep MI and higher CA125 levels were more significant in patients with high-grade EC (HGEC) and LNM than in patients without LNM. The predictive performance of LNM in the HGEC group was higher than that in the LGEC group (AUC = 0.84 and 0.75, respectively). Patients in the group without postoperative pathological LNM and positive LNM prediction had significantly worse relapse-free and overall survival than patients with negative LNM prediction (log-rank test, P < 0.01). This study showed that preoperative clinicopathological factors can predict LNM with high precision and detect patients with poor prognoses. Furthermore, clinicopathological factors associated with LNM were different between HGEC and LGEC patients.
引用
收藏
相关论文
共 44 条
  • [1] Bray F(2018)Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J. Clin. 68 394-424
  • [2] Katanoda K(2021)Updated trends in cancer in Japan: incidence in 1985–2015 and mortality in 1958–2018—A sign of decrease in cancer incidence J. Epidemiol. 31 426-450
  • [3] Siegel RL(2022)Cancer statistics, 2022 CA Cancer J. Clin. 72 7-33
  • [4] Miller KD(2017)Assessing the effect of guideline introduction on clinical practice and outcome in patients with endometrial cancer in Japan: A project of the Japan society of gynecologic oncology (JSGO) guideline evaluation committee J. Gynecol. Oncol. 28 e76-278
  • [5] Fuchs HE(2014)Classification of endometrial carcinoma: More than two types Lancet Oncol. 15 e268-2064
  • [6] Jemal A(2020)Endometrial cancer N. Engl. J. Med. 383 2053-505
  • [7] Shigeta S(2005)Endometrial cancer Lancet 366 491-8
  • [8] Murali R(2011)Multivariate survival analysis of the patients with recurrent endometrial cancer J. Gynecol. Oncol. 22 3-278
  • [9] Soslow RA(2009)FIGO stage IIIC endometrial carcinoma: Prognostic factors and outcomes Gynecol. Oncol. 114 273-39
  • [10] Weigelt B(2021)ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma Int. J. Gynecol. Cancer 31 12-765